Picture EBD Group BIO-Europe 2018 Copenhagen Denmark Partnerships 600x60px
Person › Details

Joshua Elbaum (1st Detect Corporation)

Elbaum, Joshua (Astrotech 201312 VP Marketing at 1st Detect Corp)


Organisation Organisation 1st Detect Corporation
  Group Astrotech (Group)
Products Product 1st Detect Miniature Chemical Detector
  Product 2 MMS-1000™ Miniature Mass Spectrometer

1st Detect Corporation. (12/10/13). "Press Release: 1st Detect Awarded U.S. Patent for Novel Mass Spectrometer Design". Austin, TX.

1st Detect Corporation, a subsidiary of Astrotech Corporation (ASTC), announced today that the United States Patent Office ("USPTO") has allowed the issuance of a key patent for the company's unique ion trap used for chemical analysis and detection. "We are extremely pleased that the USPTO has allowed this patent. This patent is an important component of our intellectual property portfolio as it allows 1st Detect to enhance the performance of miniaturized mass spectrometers without an increase in size or cost," said Thomas B Pickens III, Chairman and CEO of 1st Detect. "The patent clearly validates our technology, while both demonstrating and protecting the progress we have made in the development of the 1st Detect mass spectrometer."

The patent, entitled "A Mass Spectrometer Ion Trap Having Asymmetric End Cap Apertures", published as USPTO No. 8,610,055, represents a key technological advantage for 1st Detect to improve the sensitivity and resolution of small mass spectrometers without increasing the complexity or cost of the instrument.

"The technology protected by this patent supports our objective to offer the most affordable, high performance small mass spectrometer for both laboratory and field applications," added David Rafferty, the inventor of the novel technology and President and CTO of 1st Detect.

1st Detect Corporation has developed an instrument that revolutionizes the chemical detection and analysis market by delivering lab performance mass spectrometry in a small, affordable and easily portable package. The 1st Detect mass spectrometer's broad capabilities make it an ideal tool for a variety of applications in the research, security, industrial, process flow and healthcare markets; and is capable of detecting a wide variety of chemicals including residues and vapors from explosives, chemical warfare agents, toxic chemicals, food and beverage contaminants, and pollution products.

About 1st Detect Corporation

1st Detect Corporation was formed by Astrotech Corporation (ASTC) to develop and commercialize miniature mass spectrometer technology first developed under an agreement with NASA for use on the International Space Station. 1st Detect offers a breakthrough miniature mass spectrometer that fills an unmet need by being highly accurate, rapid, lightweight, and cost-effective. For more information on 1st Detect Corporation, please visit

About Astrotech Corporation

Astrotech is one of the first space commerce companies and remains a strong entrepreneurial force in the aerospace industry. We are leaders in identifying, developing and marketing space technology for commercial use. Our Astrotech Space Operations business unit serves our government and commercial satellite and spacecraft customers with pre-launch services on the eastern and western range. 1st Detect Corporation has developed a breakthrough miniature mass spectrometer, while Astrogenetix, Inc. is a biotechnology company utilizing microgravity as a research platform for drug discovery and development.

This press release contains forward-looking statements that are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to risks, trends, and uncertainties that could cause actual results to be materially different from the forward-looking statement. These factors include, but are not limited to, continued government support and funding for key space programs, product performance and market acceptance of products and services, as well as other risk factors and business considerations described in the Company's Securities and Exchange Commission filings including the annual report on Form 10-K. Any forward-looking statements in this document should be evaluated in light of these important risk factors. The Company assumes no obligation to update these forward-looking statements.


Joshua Elbaum
VP, Marketing
+1 (512) 485-9530

Record changed: 2016-03-19


Picture [iito] – Putting Information into Context 600x102px

More documents for Joshua Elbaum

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture [LSE] – The Business Web Portal 600x80px

» top